Concepedia

James M. Gudgeon

JM

Statistics

Publications

8

Citations

328

H-Index

8

Active since

2009

Affiliations

Intermountain Healthcare(Current)

Geisinger Health System

Harvard Pilgrim Health Care

Cornell University

Harvard University

James M. Gudgeon is an author at Intermountain Healthcare specializing in medicine, oncology, and colorectal cancer screening.

ORCID

Publications per year

2009–2021

8

Publications

8

A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing

Lisa M. Meckley, James M. Gudgeon, Jeffrey L. Anderson et al. · PharmacoEconomics · 2009 · 98 citations

, , +14

Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts

Alanna Kulchak Rahm, Deborah Cragun, Jessica Ezzell Hunter et al. · BMC Health Services Research · 2018 · 62 citations · Full text

, , +17

Lynch syndrome screening implementation: business analysis by a healthcare system.

James M. Gudgeon, Janet L Williams, Randall W. Burt et al. · PubMed · 2011 · 49 citations

, , +17

Targeted gene panel sequencing for the rapid diagnosis of acutely ill infants

Luca Brunelli, Sabrina Malone Jenkins, James M. Gudgeon et al. · Molecular Genetics & Genomic Medicine · 2019 · 45 citations · Full text

, , +17

Cost or price of sequencing? Implications for economic evaluations in genomic medicine

Scott D. Grosse, James M. Gudgeon · Genetics in Medicine · 2021 · 21 citations · Full text

, , +17

1–5 of 8